Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David J. Perry, MD
Medstar Health Research Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- Franklin Square Hospital Center
Baltimore, Maryland, United States
- Good Samaritan Hospital of Maryland
Baltimore, Maryland, United States
- Harbor Hospital Center
Baltimore, Maryland, United States
- Union Memorial Hospital
Baltimore, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2000
- Primary completion
- 15 Nov 2001
- Completion
- 10 Sept 2002
- Last update posted
- 18 Aug 2020
- Registered enrollment
- 4
- Registry id
- NCT00006472
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.